Abstracts

Search by keyword or author name.

Showing 851 abstracts.

Mark J. Abzug, M.D., Stephen Ira Pelton, M.D., Lin-Ye Song, Ph.D., Myron Levin, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Howard Max Rosenblatt, M.D., William Borkowsky, M.D. Predictors of Response to Pneumococcal Conjujagate Vaccine (PCV) + Pneumococcal Polysaccharide Vaccine (PPV) in HIV-infected Children Treated with HAART ( PACTG 1024).

Study

P1024
Mark Mirochnick, M.D., Yvonne J. Bryson, M.D., Alice M. Stek, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James D. Connor, M.D., Heather D. Watts, M.D., Sharon Huang, M.S., Michael Hughes, Ph.D., Bethann Cunningham, B.S., Michael Hughes, Ph.D., Lynette Purdue, Pharm.D., Yetemegnu Asfaw, B.S., Elizabeth (Betsy) Smith, M.D. Pharmacokinetics (PK) of Nelfinavir (NFV) and its M8 Metabolite in Pregnant HIV-Infected Women and Their Infants: PACTG 353.
Susan Schuval, M.D. GB Virus C prevalence in perinatally-infected HIV-positive children.
Akihiko Saitoh, M.D., S. Sandall, Kumud K. Singh, Christine Powell, M.A., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D., Karen Hsia, Ph.D., Stephen A. Spector, M.D. New Thymic Emigrants as Determined by T-cell Receptor Excision Circles (TREC) are Associated with the CD4+ Lymphocytes and Intracellular DNA Levels in HIV-1 infected Children Before and During Sustained, Undetectable Plasma HIV-1 RNA.
G. M. Ellis, William Borkowsky, M.D., Ram Yogev, M.D., Bonnie J. Ank, Petronella Muresan, M.S., Terence Fenton, Ed.D., Barbara E. Heckman, B.S., Elizabeth (Betsy) J. McFarland, M.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D., Lisa M. Frenkel, M.D. Viral populations with distinct drug-resistant genotypes shift during repeated STI.

Study

P1015
Ram Yogev, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Elizabeth (Betsy) J. McFarland, M.D., Lisa M. Frenkel, M.D., Edmund Capparelli, Pharm.D., Barbara E. Heckman, B.S., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D. Virologic and Clinical Outcomes of a Progressively Increasing Structured Treatment Interruption Study in Chronically-infected Children.

Study

P1015
Ellen Gould Chadwick, M.D., Paul Palumbo, M.D., John H. Rodman, Pharm.D., Katherine Luzuriaga, M.D., Paula Britto, M.S., Ram Yogev, M.D. Early Therapy with Ritonavir (RTV), ZDV and 3TC in HIV-1 Infected Children 1-24 months of Age.
Elizabeth (Betsy) Smith, M.D. Ongoing nucleoside safety review of HIV-exposed children in US studies.
Miriam Chernoff, Ph.D., Paige L. Williams, Ph.D., Pim Brouwers, Ph.D., Jerry D. Heston, M.D., Kenneth D. Gadow, Ph.D., Sharon Appelbaum Nachman, M.D. HIV Disease Severity and Psychiatric Symptoms in HIV-Infected Children and Adolescents Enrolled in PACTG P1055.

Study

P1055
Mark Mirochnick, M.D., Alice M. Stek, M.D., Edmund Capparelli, Pharm.D., Brookie M. Best, Pharm.D., Stephen J. Rossi, Pharm.D., Sandra K. Burchett, M.D., M.S., ChengCheng Hu, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H. Atazanavir Pharmacokinetics with and without Tenofovir During Pregnancy.

Study

P1026S